Analyst cuts Rockwell Medical fair value to USD 20 for Rockwell Medical stock

Published on 10/02/2026 at 00:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The sale covers 1,000 shares valued at USD 8,400.00 on October 1, 2026. Rockwell Medical stock is valued at USD 33.8 million.

RMTI, US7743743004, Illustration mit AI erstellt.

AnalystHighTarget cut Rockwell Medical's fair value from USD 40.00 to USD 20.00 on October 1, 2026, according to Simply Wall St. The revision puts valuation discipline at the center of the latest RMTI discussion, while the company continues to point to sales growth in 2026.

Fair value falls to USD 20

The change cuts the stated valuation reference by 50.00 percent from USD 40.00, with Simply Wall St attributing the move to a lower future price-to-earnings assumption and slightly reduced revenue-growth and profit-margin expectations.

The same update says Rockwell Medical reiterated 2026 net sales guidance of USD 70.0 million to USD 75.0 million. That guidance is a range rather than a single-point forecast, leaving the next quarterly report as the next major test of execution.

Second-quarter revenue rises 10.6 percent

Rockwell Medical reported second-quarter 2026 revenue of USD 17.8 million, up 10.6 percent year over year, while gross margin reached 18.2 percent, according to ToAlpha. Operating cash flow was USD 2.1 million in the quarter, giving the revenue increase a cash-generation component.

Net income remained negative at USD 1.2 million in the second quarter of 2026, while the company held USD 10.5 million in cash. The combination of year-over-year growth, positive operating cash flow and a quarterly loss explains why the valuation debate depends on future margin improvement rather than revenue alone.

Nasdaq quote and insider filing

Rockwell Medical officer Mark Strobeck proposed the sale of 1,000 common shares for an aggregate USD 8,400.00 on October 1, 2026, according to StockTitan. The filing listed Nasdaq and 4,030,465 shares outstanding, making the proposed transaction small relative to the reported share count.

RMTI was last at USD 8.57 on Nasdaq on October 1, 2026 at 4:00 p.m. ET. Its market capitalization was USD 33.8 million, and the 52-week range was USD 4.89 to USD 12.90 on the same date.